Vivos Therapeutics
VVOS
VVOS
29 hedge funds and large institutions have $10.9M invested in Vivos Therapeutics in 2021 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.23% more ownership
Funds ownership: 0.18% → 0.41% (+0.23%)
Holders
29
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.9M | |
| 2 | +$1.11M | |
| 3 | +$1.07M | |
| 4 |
ACM
Archon Capital Management
Seattle,
Washington
|
+$1.06M |
| 5 |
PCM
Perkins Capital Management
Wayzata,
Minnesota
|
+$804K |
Top Sellers
| 1 | -$324K | |
| 2 | -$302K | |
| 3 | -$206K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$105K |
| 5 |
APP
Alpha Paradigm Partners
Chicago,
Illinois
|
-$66K |